Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?

Chronic kidney disease (CKD) is a progressive impairment of renal function for more than three months that affects 15% of the adult population. Because oxidative stress is involved in its pathogenesis, antioxidants are under study for the prophylaxis of CKD progression. The objective of this work wa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alfredo G. Casanova, Francisco J. López-Hernández, Laura Vicente-Vicente, Ana I. Morales
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/33a6e40a6104402bab1572765290fa73
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:33a6e40a6104402bab1572765290fa73
record_format dspace
spelling oai:doaj.org-article:33a6e40a6104402bab1572765290fa732021-11-25T16:25:44ZAre Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?10.3390/antiox101116692076-3921https://doaj.org/article/33a6e40a6104402bab1572765290fa732021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1669https://doaj.org/toc/2076-3921Chronic kidney disease (CKD) is a progressive impairment of renal function for more than three months that affects 15% of the adult population. Because oxidative stress is involved in its pathogenesis, antioxidants are under study for the prophylaxis of CKD progression. The objective of this work was to meta-analyze the efficacy of antioxidant therapy in CKD patients and to identify the most effective candidate antioxidants. Our meta-analysis showed that, despite being quite heterogeneous, overall antioxidant therapy apparently reduced CKD progression. Pentoxifylline and bardoxolone methyl demonstrated a robust and statistically significant protection, while other products showed a favorable but non-significant tendency, due to a high interindividual variability. Off-target (i.e., antioxidant-independent) effects, such as body weight reduction and heart failure-associated blood dilution, might totally or partially explain the protection provided by effective antioxidants. This potential pleiotropy introduces uncertainty on the role of oxidative stress in CKD progression and on antioxidant therapy in its prevention, which needs to be further investigated. Independently, identification of factors determining the nephroprotective effect of each candidate on each patient is thus necessary for a prospectively personalized antioxidant therapy. Finally, pentoxifylline should be further explored for the prophylaxis of CKD progression.Alfredo G. CasanovaFrancisco J. López-HernándezLaura Vicente-VicenteAna I. MoralesMDPI AGarticlechronic kidney diseaseantioxidantsmeta-analysisbardoxolone methylpentoxifyllinenephroprotectionTherapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1669, p 1669 (2021)
institution DOAJ
collection DOAJ
language EN
topic chronic kidney disease
antioxidants
meta-analysis
bardoxolone methyl
pentoxifylline
nephroprotection
Therapeutics. Pharmacology
RM1-950
spellingShingle chronic kidney disease
antioxidants
meta-analysis
bardoxolone methyl
pentoxifylline
nephroprotection
Therapeutics. Pharmacology
RM1-950
Alfredo G. Casanova
Francisco J. López-Hernández
Laura Vicente-Vicente
Ana I. Morales
Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?
description Chronic kidney disease (CKD) is a progressive impairment of renal function for more than three months that affects 15% of the adult population. Because oxidative stress is involved in its pathogenesis, antioxidants are under study for the prophylaxis of CKD progression. The objective of this work was to meta-analyze the efficacy of antioxidant therapy in CKD patients and to identify the most effective candidate antioxidants. Our meta-analysis showed that, despite being quite heterogeneous, overall antioxidant therapy apparently reduced CKD progression. Pentoxifylline and bardoxolone methyl demonstrated a robust and statistically significant protection, while other products showed a favorable but non-significant tendency, due to a high interindividual variability. Off-target (i.e., antioxidant-independent) effects, such as body weight reduction and heart failure-associated blood dilution, might totally or partially explain the protection provided by effective antioxidants. This potential pleiotropy introduces uncertainty on the role of oxidative stress in CKD progression and on antioxidant therapy in its prevention, which needs to be further investigated. Independently, identification of factors determining the nephroprotective effect of each candidate on each patient is thus necessary for a prospectively personalized antioxidant therapy. Finally, pentoxifylline should be further explored for the prophylaxis of CKD progression.
format article
author Alfredo G. Casanova
Francisco J. López-Hernández
Laura Vicente-Vicente
Ana I. Morales
author_facet Alfredo G. Casanova
Francisco J. López-Hernández
Laura Vicente-Vicente
Ana I. Morales
author_sort Alfredo G. Casanova
title Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?
title_short Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?
title_full Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?
title_fullStr Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?
title_full_unstemmed Are Antioxidants Useful in Preventing the Progression of Chronic Kidney Disease?
title_sort are antioxidants useful in preventing the progression of chronic kidney disease?
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/33a6e40a6104402bab1572765290fa73
work_keys_str_mv AT alfredogcasanova areantioxidantsusefulinpreventingtheprogressionofchronickidneydisease
AT franciscojlopezhernandez areantioxidantsusefulinpreventingtheprogressionofchronickidneydisease
AT lauravicentevicente areantioxidantsusefulinpreventingtheprogressionofchronickidneydisease
AT anaimorales areantioxidantsusefulinpreventingtheprogressionofchronickidneydisease
_version_ 1718413191977893888